Shots:
Saluda Medical has reported full commercial launch of EVA in the US following its approval in Dec 2024
Saluda Medical will present new clinical data on EVA and the Evoke SmartLoop System at ASPN 2025, featuring 11 abstracts, one oral presentation, & over 37 total publications, incl. 36-month efficacy results from the EVOKE Study…
